The Many Faces of Interleukin-6: The Role of IL-6 in Inflammation, Vasculopathy, and Fibrosis in Systemic Sclerosis PDF Print E-mail
Wednesday, 21 March 2012 20:39
Theresa C. Barnes,Marina E. Anderson, and Robert J.Moots
Received 1 June 2011; Accepted 21 July 2011

Systemic sclerosis (SSc) is a connective tissue disease characterised by fibrosis, vasculopathy, and immunological abnormalities. Over recent years, it has become clear that inflammation plays a crucial role in mediating the pathophysiological process underlying SSc, especially early in the disease. Endothelial cell activation and dysfunction are central to the disease pathogenesis, may be driven by a proinflammatory environment, and may result in the generation of a profibrotic phenotype.

Interleukin-6 (IL-6) is a pleiotropic cytokine. In addition to its role in the acute phase response, IL-6 has diverse roles in driving chronic inflammation, autoimmunity, endothelial cell dysfunction, and fibrogenesis. Therefore, it is currently attracting a great deal of interest in the rheumatology community as a potential therapeutic agent in SSc, a disease which at present lacks treatments directed at the underlying pathogenesis.

Recent evidence has suggested that IL-6 may play important roles in endothelial cell dysfunction and fibrogenesis in this disease, and clinical trials are currently being designed to further explore whether Tocilizumab, a monoclonal antibody directed against the IL-6 receptor, may be of therapeutic benefit to patients with SSc.

Continue reading the full review article, by downloading it from the link provided below.

 
More articles :

» Erectile Dysfunction is Frequent in Systemic Sclerosis and Associated with Severe Disease: A Study of the EULAR Scleroderma Trial and Research Group

Chingching Foocharoen, Alan Tyndall, Eric Hachulla, Edoardo Rosato, Yannick Allanore, Dominique Farge-Bancel, Paola Caramaschi, Paolo Airó, Starovojtova M Nikolaevna, José A Pereira da Silva, Bojana Stamenkovic, Gabriela Riemekasten, Simona...

» Pulmonary Arterial Hypertension Occurrence After Liver Transplant in Systemic Sclerosis

E. Koumakis, J. Wipff, A. Kahan, Y. AllanoreReceived on January 12, 2010; accepted in revised form on April 20, 2010.Clin Exp Rheumatol 2010: 28 (Suppl. 58): S53-S54.© Copyright CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 2010.E. Koumakis, J. Wipff, A....

» We Need Your Help!

Today, the Scleroderma Care Foundation embarks upon a mission of vital importance, and we are counting on your help. One of our dearest patients and friend, , is on the verge of Renal or and we are seeking out a qualified kidney donor. Currently,...

» Causes Found for Stiff Skin Conditions

By studying the genetics of a rare inherited disorder called stiff skin syndrome, researchers at the Johns Hopkins University School of Medicine have learned more about , a condition affecting about one in 5,000 people that leads to hardening of the...

» Unite Against Scleroderma

On May 1st 2011, the would be holding its first annual "Unite Against Scleroderma" Walk around the Queen's Park Savannah, Port Of Spain. It is our aim to help raise awareness of this rare autoimmune disease and the funding needed to aid those who...

» Face Exercises for Scleroderma

Scleroderma is caused by too much collagen in your body, which causes hardening, thickening and tightening of your skin and connective tissues. In localized scleroderma, only your skin is involved; systemic scleroderma damages your inner organs,...

Add comment

Do feel free to leave your comments, as they would add value and knowledge to the community. However, please refrain from making any disparaging, uninformed, or unrelated comments. Thanks :)

Security code
Refresh

Login



Wise Words

"Happiness can only be found if you free yourself from all other distractions"
Saul Bellow

"Never let your sense of morals prevent you from doing what's right"
Isaac Asimov

"Before someone's tomorrow has been taken away, cherish those you love, appreciate them today"
Michelle C. Ustaszeski